Ralph Toelg
Overview
Explore the profile of Ralph Toelg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1032
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunadian V, Gitto M, Vogel B, Sartori S, Angiolillo D, Bhatt D, et al.
JACC Cardiovasc Interv
. 2025 Feb;
PMID: 39969452
Background: In patients at high bleeding risk (HBR), short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is associated with reduced bleeding and preserved ischemic protection. Objectives: The aim...
2.
Byrne R, Hahn J, OKane P, Sabate M, Toelg R, Copt S, et al.
JACC Cardiovasc Interv
. 2025 Feb;
18(5):654-662.
PMID: 39918494
Background: In recent years, drug-coated balloon (DCB) angioplasty has become an established treatment option for the treatment of coronary in-stent restenosis (ISR). Objectives: The aim of this study was to...
3.
Mankerious N, Toelg R, Abdelghani M, Garcia-Garcia H, Farhan S, Allali A, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Jan;
PMID: 39761745
Introduction And Objectives: Patients undergoing percutaneous coronary intervention in vessels with moderate-to-severe tortuosity are at higher risk of adverse outcomes, but data are scarce in the era of newer-generation stents....
4.
Elbasha K, Alotaibi S, Samy M, Mankerious N, Toelg R, Geist V, et al.
Clin Res Cardiol
. 2024 Dec;
PMID: 39714509
Background: Coronary physiology to guide multi-vessel coronary intervention is associated with better outcome. In the presence of a coronary chronic total occlusion (CTO), hemodynamic evaluation of intermediate lesions in the...
5.
Alotaibi S, Elbasha K, Bradai M, Landt M, Kurniadi A, Abdel-Wahab M, et al.
Clin Res Cardiol
. 2024 Oct;
PMID: 39432016
Background: Planning noncardiac surgery after transcatheter aortic valve implantation (TAVI) is challenging. We evaluated the incidence, characteristics, and outcome of noncardiac surgeries in patients who underwent TAVI. Methods: We retrieved...
6.
Samy M, Landt M, Mankerious N, Kurniadi A, Alotaibi S, Toelg R, et al.
Catheter Cardiovasc Interv
. 2024 Oct;
104(6):1251-1259.
PMID: 39378384
Background: The hybrid strategy combining plug-based and suture-based vascular closure devices (VCD) was introduced as a promising technique for vascular access hemostasis after transcatheter aortic valve implantation (TAVI) with satisfactory...
7.
Seguchi M, Aytekin A, Xhepa E, Haude M, Wlodarczak A, van der Schaaf R, et al.
EuroIntervention
. 2024 Sep;
20(18):e1173-e1183.
PMID: 39279514
Background: The 12-month outcomes of BIOMAG-I - the first-in-human study investigating the third-generation drug-eluting resorbable magnesium scaffold (DREAMS 3G) - showed promising results regarding clinical outcomes and late lumen loss....
8.
Mankerious N, Toelg R, Vogel B, Sartori S, Angiolillo D, Vranckx P, et al.
Am J Cardiol
. 2024 Jun;
225():25-34.
PMID: 38871156
Shortening the duration of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) was shown to be effective and safe in patients at high bleeding risk (HBR). We aimed to investigate...
9.
Samy M, Alali A, Elbasha K, Amoey D, Hemetsberger R, Kandil N, et al.
Clin Res Cardiol
. 2024 Jun;
113(7):1070-1080.
PMID: 38832996
Background: Severely calcified coronary bifurcations complicate percutaneous coronary interventions (PCI) and often necessitate dedicated lesion preparation. We compared the outcomes of single- versus two-stent techniques for treating heavily calcified true...
10.
Cao D, Vranckx P, Valgimigli M, Sartori S, Angiolillo D, Bangalore S, et al.
EuroIntervention
. 2024 May;
20(10):e630-e642.
PMID: 38776146
Background: A short dual antiplatelet therapy (DAPT) duration has been proposed for patients at high bleeding risk (HBR) undergoing drug-eluting coronary stent (DES) implantation. Whether this strategy is safe and...